 Updated News [1] |
Denmark's Zealand Pharma starts Phase I diabetes drug trials [2]
Chicago Tribune “ZP2929 may turn out to address a large unmet medical need in the field of metabolic diseases, namely better treatment of patients with diabetes and/or patients who are overweight or obese,” Chief Scientific Officer Christian Grondahl said in a statement. Zealand Pharma Advances ZP2929 Into Phase I Development for the Treatment … [3]MarketWatch (press release) all 16 news articles » [4] |
More details can be found at www.diabeteshowto.com [5]